What is the recommended treatment protocol for migraines using triptans (serotonin receptor agonists)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triptan Treatment Protocol for Migraines

Triptans should be used as second-line therapy in patients whose migraine attacks do not respond to NSAIDs, with specific oral options including naratriptan, rizatriptan, zolmitriptan, and sumatriptan. 1

Treatment Algorithm for Migraine Using Triptans

First-Line Treatment

  • NSAIDs are the first-line treatment for most patients with migraine (aspirin, ibuprofen, naproxen sodium, or acetaminophen-aspirin-caffeine combination) 1
  • Acetaminophen alone is ineffective for migraine treatment 1

Second-Line Treatment: Triptans

  • Initiate triptans when NSAIDs fail to provide adequate relief 1
  • Recommended triptans with good evidence for efficacy:
    • Oral naratriptan
    • Oral rizatriptan (most effective with highest clinical effectiveness rating) 2
    • Oral zolmitriptan
    • Oral and subcutaneous sumatriptan 1

Dosing Guidelines

  • Sumatriptan:
    • Available doses: 25mg, 50mg, or 100mg orally 3
    • Maximum daily dose: 200mg in a 24-hour period 3
    • A second dose may be administered if migraine hasn't resolved after 2 hours or returns after transient improvement 3
    • Doses must be separated by at least 2 hours 3
  • Rizatriptan:
    • Available in doses of 5-20mg orally every two hours 2
    • Maximum daily dose: 30mg 2
    • Available as orally disintegrating wafers for patients with significant nausea 2, 4

Route of Administration Selection

  • Use non-oral routes when nausea or vomiting are significant components of migraine attacks 1
  • Options include:
    • Subcutaneous sumatriptan 1
    • Intranasal formulations (sumatriptan, zolmitriptan) 1, 5
    • Orally disintegrating tablets (rizatriptan) for patients with nausea 2, 4

Important Contraindications and Precautions

Absolute Contraindications

  • Uncontrolled hypertension 1, 3
  • Basilar or hemiplegic migraine 1, 3
  • Coronary artery disease or risk factors for heart disease 1, 3
  • History of stroke, transient ischemic attack 3
  • Peripheral vascular disease 3
  • Ischemic bowel disease 3
  • Use within 24 hours of another triptan or ergotamine-containing medication 3
  • Concurrent or recent (past 2 weeks) use of MAO inhibitors 3
  • Severe hepatic impairment 3

Dose Adjustments

  • For patients with mild to moderate hepatic impairment, maximum single dose of sumatriptan should not exceed 50mg 3

Monitoring for Adverse Effects

  • Common side effects include paresthesia, warm/cold sensation, chest pain/tightness/pressure, neck/throat/jaw pain/tightness/pressure, vertigo, and fatigue 3
  • Monitor for medication overuse headache - limit use to no more than twice weekly 1, 4
  • Watch for signs of serotonin syndrome, especially when combined with SSRIs 3

Triptan Selection Strategy

  • Try a triptan for 2-3 migraine episodes before determining effectiveness 4
  • If one triptan is ineffective, try a different triptan 4
  • Rizatriptan 10mg has demonstrated superior efficacy with faster pain relief compared to other triptans 2
  • Consider adding metoclopramide 10mg to sumatriptan for triptan-nonresponsive migraineurs 6

Special Considerations

  • For patients with significant nausea, consider orally disintegrating tablets or non-oral routes 2, 4
  • Triptans may be effective for cluster headaches in addition to migraines 7
  • Consider preventive therapy if acute treatments are used more than twice weekly or if patient experiences two or more migraine attacks per month with disability lasting three or more days 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Migraine Treatment with Rizatriptan and Eletriptan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rizatriptan Dosage and Administration for Acute Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Triptans: over the migraine.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.